TY - JOUR
AU - Christgau, S.
AB - Calcif Tissue Int (2001) 69:130–137 DOI: 10.1007/s002230020042 © 2001 Springer-Verlag New York Inc. Clinical Investigations Bone Resorption in Post-menopausal Women with Normal and Low BMD Assessed with Biochemical Markers Specific for Telopeptide Derived Degradation Products of Collagen Type I 1,2 2 3 4 2 2 4 J.-Y. Reginster, Y. Henrotin, C. Christiansen, E. Gamwell-Henriksen, O. Bruyere, J. Collette, S. Christgau WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders Bone and Cartilage Metabolism Unit, University of Lie `ge, Lie `ge, Belgium Center for Clinical and Basic Research, Ballerup, Denmark Osteometer Bio Tech A/S, Herlev, Denmark Received: 22 November 2000 / Accepted: 1 May 2001 / Online publication: 8 August 2001 Abstract. Biochemical markers of bone resorption can be Key words: Osteoporosis — Biochemical markers — Bone used clinically to predict the risk of osteoporosis-related turnover — Collagen type I — Antiresorptive therapies — fractures (prognostic tool) and to assess the response of an Diagnosis. osteoporotic patient to an antiresorptive therapy (monitoring tool). Our aim was to assess the ability of four currently marketed biochemical markers of bone resorption, based on the measurement of degradation products from collage type Assessment of bone physiology has been greatly improved I telopeptides 
TI - Bone Resorption in Post-menopausal Women with Normal and Low BMD Assessed with Biochemical Markers Specific for Telopeptide Derived Degradation Products of Collagen Type I
JF - Calcified Tissue International
DO - 10.1007/s002230020042
DA - 2014-01-31
UR - https://www.deepdyve.com/lp/springer-journals/bone-resorption-in-post-menopausal-women-with-normal-and-low-bmd-CozWl2auE2
SP - 130
EP - 137
VL - 69
IS - 3
DP - DeepDyve
ER -